In this sense, the PD-1/PD-L1 axis blockage is a promising therapeutic tool that is being successfully used in several types of malignant tumors, including kidney [67], breast [68], lung [69] and bladder [70] cancers, as well as malignant melanoma [71]. This evidence concerns the gene CD274 and cancer.